FDAnews Announces: Building a World-Class Import/Export Program: How to Comply with the FDA and US Customs, Oct. 27-28, 2014, Bethesda, MD

Share Article

Having FDA-regulated products held at ports costs time, money and the competitive edge. Here’s the one interactive workshop that arms attendees with a full program of today’s best compliance strategies for speeding products out of Customs and into US and global markets.

Building a World-Class Import/Export Program:
How to Comply with the FDA and US Customs
**Presented Encore Insight LLC and FDAnews**
Oct. 27-28, 2014 – Bethesda, MD
http://www.fdanews.com/CustomsImportExportProgram

Having FDA-regulated products held at ports costs time, money and the competitive edge. But it doesn’t have to.

Instead of risking containment, or even destruction of products, let an FDA insider show how to implement a trouble-shooting import/export program.

Here’s the one interactive workshop that arms attendees with a full program of today’s best compliance strategies for speeding products out of Customs and into US and global markets.

No more guesswork about FDA priorities, processes or technologies; no more wondering about special provisions for trade shows, personal baggage and more. Former FDA import/export expert Casper “Cap” Uldriks lays out everything manufacturers need to know to take the risks, and delays out of importing and exporting FDA-regulated products, including:

  •     How to negotiate with the FDA
  •     Registering and listing with the FDA
  •     Selecting an import broker
  •     FDA’s and U.S. Custom’s dual role
  •     Procedural fundamentals
  •     PREDICT: the FDA’s computer screening program
  •     U.S. Custom’s process and computer link to the FDA
  •     OASIS: the FDA’s computer tracking program
  •     FDA automatic detention/import alert list
  •     Special provisions: trade shows, return for repair, compassionate use, personal baggage
  •     Options when imports or exports are detained

The registration includes the two-day interactive workshop plus a comprehensive binder featuring all slides from the workshop presentations, plus a wealth of reference documents to save manufacturers time and mistakes for years to come.

Remember, there are all too many stories of products that enter ports worth $2 million that end up getting destroyed by the FDA and U.S. Customs or leaving the port worth just a fraction of their value.

Who Will Benefit:
This intensive hands-on training workshop is of immediate value to drug, biologics, device and diagnostics companies, as well as contract drug manufacturers, OTC companies, API suppliers, excipient suppliers, freight-forwarders and customs brokers. Personnel who will benefit the most include:

  •     Regulatory compliance officers
  •     Supply chain managers
  •     Manufacturing directors and supervisors
  •     Executive management

The Expert Instructor:
Casper “Cap” Uldriks, founder of Encore Insight LLC provides consulting and training on FDA law and operations. Most recently he was counsel at Olsen Frank Weeda Law. With more than 30 years at the FDA he held a number of positions within the agency, such as an investigator in FDA’s New England office, in the Office of the Commissioner in Legislative Affairs and in CDRH, where he served as CDRH's Associate Director for Regulatory Guidance and Government Affairs.

Conference Details:
Building a World-Class Import/Export Program:
How to Comply with the FDA and US Customs
**Presented Encore Insight LLC and FDAnews**
Oct. 27-28, 2014 – Bethesda, MD
http://www.fdanews.com/CustomsImportExportProgram

Tuition: $1,797

Easy Ways to Register:
Online: http://www.fdanews.com/CustomsImportExportProgram
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website